Association between cystic fibrosis transmembrane conductance regulator gene mutations and susceptibility for Childhood Asthma in Korea

Yonsei Medical Journal

Volumn 51, Issue 6, 2010, Pages 912-917

  Kim, Kyung Won ^a   Lee, Ji Hyun ^a   Lee, Min Goo ^a   Kim, Kyung Hwan ^a   Sohn, Myung Hyun ^a   Kim, Kyu Earn ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Asthma; Children; Cystic fibrosis transmembrane conductance regulator

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALGORITHM; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHILD; CHILDHOOD ASTHMA; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; SCHOOL CHILD; SOUTH KOREA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ASTHMA; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTORY, ANCIENT; HUMANS; MALE; MUTATION; REPUBLIC OF KOREA;

EID: 77957969494     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2010.51.6.912     Document Type: Article

References (29)

1. Maselli R, Paciocco G. Asthma: pathophysiology of the bronchial obstruction. Allergy 2000;55 Suppl 61:49-51.
2. Shin JW, Sue JH, Song TW, Kim KW, Kim ES, Sohn MH, et al. Atopy and house dust mite sensitization as risk factors for asthma in children. Yonsei Med J 2005;46:629-34.
3. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med 2002;53:477-98.
4. Sengler C, Lau S, Wahn U, Nickel R. Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res 2002;3:7.
5. Nam HS, Lee SY, Kim SJ, Kim JS, Kwon SS, Kim YK, et al. The soluble tumor necrosis factor-alpha receptor suppresses airway inflammation in a murine model of acute asthma. Yonsei Med J 2009;50:569-75.
6. Kim SH, Ye YM, Hur GY, Lee HY, Jee YK, Lee SH, et al. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment. Yonsei Med J 2009;50:182-8.
7. Munthe-Kaas MC, Lødrup Carlsen KC, Carlsen KH, Skinningsrud B, Håland G, Devulapalli CS, et al. CFTR gene mutations and asthma in the Norwegian Environment and Childhood Asthma study. Respir Med 2006;100:2121-8.
8. Moon HR, Ko TS, Ko YY, Choi JH, Kim YC. Cystic fibrosis--a case presented with recurrent bronchiolitis in infancy in a Korean male infant. J Korean Med Sci 1988;3:157-62.
9. Ahn KM, Park HY, Lee JH, Lee MG, Kim JH, Kang IJ, et al. Cystic fibrosis in Korean children: a case report identified by a quantitative pilocarpine iontophoresis sweat test and genetic analysis. J Korean Med Sci 2005;20:153-7.
10. Koh WJ, Ki CS, Kim JW, Kim JH, Lim SY. Report of a Korean patient with cystic fibrosis, carrying Q98R and Q220X mutations in the CFTR gene. J Korean Med Sci 2006;21:563-6.
11. Lee JH, Choi JH, Namkung W, Hanrahan JW, Chang J, Song SY, et al. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet 2003;12:2321-32.
12. Lee KH, Ryu JK, Yoon WJ, Lee JK, Kim YT, Yoon YB. Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 2005;50:1852-6.
13. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29.
14. Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004;114:568-74.
15. Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS, et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 2002;12:437-50.
16. Niu T, Qin ZS, Xu X, Liu JS. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 2002;70:157-69.
17. Mennie M, Gilfillan A, Brock DJ, Liston WA. Heterozygotes for the delta F508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1995;1:978-9.
18. de Cid R, Chomel JC, Lazaro C, Sunyer J, Baudis M, Casals T, et al. CFTR and asthma in the French EGEA study. Eur J Hum Genet 2001;9:67-9.
19. Castellani C, Quinzii C, Altieri S, Mastella G, Assael BM. A pilot survey of cystic fibrosis clinical manifestations in CFTR mutation heterozygotes. Genet Test 2001;5:249-54.
20. Ngiam NS, Chong SS, Shek LP, Goh DL, Ong KC, Chng SY, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Asians with chronic pulmonary disease: a pilot study. J Cyst Fibros 2006;5:159-64.
21. Hakonarson H, Bjornsdottir US, Ostermann E, Arnason T, Adalsteinsdottir AE, Halapi E, et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med 2001;164:2036- 44.
22. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 1998;351:1911-3.
23. Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, Pouliou E, et al. CFTR gene mutations--including three novel nucleotide substitutions--and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 2001;108:216-21.
24. Douros K, Loukou I, Doudounakis S, Tzetis M, Priftis KN, Kanavakis E. Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations. Int J Clin Exp Med 2008;1:345-9.
25. Lázaro C, de Cid R, Sunyer J, Soriano J, Giménez J, Alvarez M, et al. Missense mutations in the cystic fibrosis gene in adult patients with asthma. Hum Mutat 1999;14:510-9.
26. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR delta F508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med 1995;1:703-5.
27. Cuppens H, Teng H, Raeymaekers P, De Boeck C, Cassiman JJ. CFTR haplotype backgrounds on normal and mutant CFTR genes. Hum Mol Genet 1994;3:607-14.
28. Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A. Fifteenyear follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. J Allergy Clin Immunol 2001;107:818-23.
29. Byard PJ, Davis PB. Pulmonary function in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis 1988;138:312-6.